Sequential dose-intensive paclitaxel plus ifosfamide and carboplatin plus etoposide with autologous stem cell transplantation for germ cell tumor (GCT) patients (pts).

被引：0
|
作者：
Kondagunta, GV [1 ]
Bacik, J [1 ]
Bajorin, DF [1 ]
Reich, L [1 ]
Sheinfeld, J [1 ]
Bains, M [1 ]
Bosl, GJ [1 ]
Motzer, RJ [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：378S / 378S
页数：1
相关论文
共 50 条
  • [11] DOSE-INTENSIVE IFOSFAMIDE/CARBOPLATIN/ETOPOSIDE PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOR NONSMALL CELL LUNG-CANCER
    PALACKDHARRY, CS
    KRIGEL, RL
    SEMINARS IN ONCOLOGY, 1994, 21 (03) : 6 - 11
  • [12] Nephrotoxicity of high-dose ifosfamide/carboplatin/etoposide in adults undergoing autologous stem cell transplantation
    Agaliotis, DP
    Ballester, OF
    Mattox, T
    Hiemenz, JW
    Fields, KK
    Zorsky, PE
    Goldstein, SC
    Perkins, JB
    Rosen, RM
    Elfenbein, GJ
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1997, 314 (05): : 292 - 298
  • [13] Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide for Patients With Relapsed Primary Mediastinal Nonseminomatous Germ Cell Tumors: Benefit From Chemotherapy, Surgery, or Both?
    Einhorn, Lawrence H.
    Abonour, Rafat
    Kesler, Kenneth A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (35) : E739 - E739
  • [14] Phase II-study of sequential High-Dose-Chemotherapy with Paclitaxel, Ifosfamide, Carboplatin, Etoposide (P-ICE) in patients with relapsed or refractory germ cell tumors (GCT)
    Cygon, F.
    Meinert, F.
    Hammad, K.
    Kegel, T.
    Steinbach, F.
    Seseke, F.
    Schmoll, H. -J.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 10 - 11
  • [15] HIGH-DOSE IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE WITH AUTOLOGOUS STEM-CELL SUPPORT
    MEISENBERG, BR
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) : 1826 - 1826
  • [16] Ifosfamide, carboplatin and etoposide for autologous stem cell transplantation in non-Hodgkin lymphomas
    Nassi, L
    Rigacci, L
    Guidi, S
    Alterini, R
    Carrai, V
    Nozzoli, C
    Saccardi, R
    Lombardini, L
    Vannucchi, AM
    Bosi, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S247 - S247
  • [17] Phase II-study of sequential high-dose-chemotherapy with paclitaxel, ifosfamide, carboplatin, etoposide(P-ICE) in patients with relapsed or refractory germ cell tumors (GCT).
    Kegel, Thomas
    Cygon, Franziska
    Meinert, Fabian Maximilian
    Hannmad, Khaled
    Steinbach, Frank
    Seseke, Florian
    Schmoll, Hans-Joachim
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [18] Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide for Patients With Relapsed Primary Mediastinal Nonseminomatous Germ Cell Tumors: Benefit From Chemotherapy, Surgery, or Both? Reply
    Feldman, Darren R.
    Bosl, George J.
    Bains, Manjit
    Motzer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (35) : E740 - E740
  • [19] P-ICE: sequential high-dose-chemotherapy with Paclitaxel, Ifosfamide, Carboplatin, Etoposide in refractory germ cell tumors
    Cygon, F.
    Meinert, F.
    Hammad, K.
    Steinbach, F.
    Seseke, F.
    Schmoll, H. -J.
    Kegel, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 95 - 95
  • [20] Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support
    Margolin, K
    Doroshow, JH
    Ahn, C
    Hamasaki, V
    Leong, L
    Morgan, R
    Raschko, J
    Shibata, S
    Somlo, G
    Tetef, M
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) : 2631 - 2637
12345